Stone disease
Allopurinol hypersensitivity syndrome: Raising awareness of an uncommon but potentially serious adverse event among kidney stone patients.
February 12, 2024
A two-sample mendelian randomization analysis excludes causal relationships between non-alcoholic fatty liver disease and kidney stones.
February 5, 2024
Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes.
February 5, 2024
Is traditional stone clinic the optimal use of NHS resources?
February 5, 2024
Modified tube cystostomy technique for management of obstructive urolithiasis in small ruminants: procedure and outcome in 17 sheep and goats.
January 22, 2024
Relocation of lower pole renal stones helps improve the stone-free rate during flexible ureteroscopy with a low complication rate.
January 15, 2024
Clinical patterns and implications of prescription opioid use in a pediatric population for the management of urolithiasis in the emergency room.
January 15, 2024
Deciphering Multi-target Pharmacological Mechanism of Cucurbita pepo Seeds against Kidney Stones: Network Pharmacology and Molecular Docking Approach.
January 15, 2024
Glycolate oxidase-1 gene variants influence the risk of hyperoxaluria and renal stone development.
January 15, 2024